IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Targeted delivery of erlotinib via hyaluronic acid-conjugated PEGylated liposomes for enhanced efficacy in A549 lung cancer cells
- Nsairat H. , et al.
2. Antimicrobial Activity Versus Virulence Potential of Hyaluronic Acid: Balancing Advantages and Disadvantages
- Korzekwa K. , et al.
3. Advances in the chemo‑preventive effects and mechanisms of ursolic acid against lung cancer (Review)
- Lin Z. , et al.
4. Therapeutic Potential of Wogonin–Aloperine Co-Amorphous for Oral Squamous Cell Carcinoma
- Wu G. , et al.
5. Ursolic acid down-regulates ANXA6 and inhibits breast cancer cell growth and metastasis
- Qian J. , et al.
6. Ursolic acid enhances radiosensitivity in esophageal squamous cell carcinoma by modulating p53/SLC7A11/GPX4 pathway-mediated ferroptosis
- Bedolla N. , et al.
7. Ursolic acid in colorectal cancer: mechanisms, current status, challenges, and future research directions
- Zhang H. , et al.
8. BTF3 affects hepatocellular carcinoma progression by transcriptionally upregulating PDCD2L and inactivating p53 signaling
- Kong M. , et al.